PLEXISION, INC.
PITSBURG, PA

Plexision, Inc. is a healthcare innovator focused on developing cellular biomarkers tailored for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. As pioneers in transplant diagnostics, Plexision's award-winning product, Pleximmune®, provides crucial testing services from their CLIA-certified lab based in Pittsburgh. The company's cutting-edge approach involves tailoring antigen-specific and non-specific cell-based assays to recreate disease conditions for personalized test results. This empowers healthcare professionals with the insights needed to make well-informed decisions about transplant recipients, supporting advancements in drug development in various areas. At Plexision, leadership is in the hands of experienced industry veterans like Rajeev Sindhi, who has steered a 20-year-long career in healthcare. He serves as Co-founder, CEO, Chairman of its Board, and Managing Director of the Sandor group in India. Rakesh Sindhi adds his deep scientific insight as Co-founder, Chief Scientific Officer, and Professor of Surgery at the University of Pittsburgh, where he developed the foundational science for Plexision's key technologies. Supporting these initiatives, Ashok Reddy, with three decades of senior management experience spanning healthcare IT sectors, directs operations. His diverse background includes leading roles like Senior Vice-President at Infinite Computer Solutions. Plexision is officially registered in Florida (F16000003024) and is headquartered at 22485 Castle Oak Road, Clarksburg, MD, incorporated as a 'FORP' on July 7, 2016. For inquiries or more information about their services, they can be reached through the phone numbers: (855) 753-9474; (412) 224-2776, and online at plexision.com.